Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel Free LIVN Stock Alerts

LivaNova (LIVN) Financials

LivaNova logo
$71.14 +1.14 (+1.62%)
As of 02:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for LivaNova

Annual Income Statements for LivaNova

This table shows LivaNova's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/24/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 58 -63 -25 -189 -158 -349 -136 -86 18 63 -242
Consolidated Net Income / (Loss)		 58 -63 -25 -189 -158 -349 -136 -86 18 63 -242
Net Income / (Loss) Continuing Operations		 58 1.87 54 -178 -158 -347 -136 -86 18 63 -242
Total Pre-Tax Income 		89 26 121 -247 -188 -348 -124 -75 -81 88 -221
Total Operating Income		 89 33 96 -248 -172 -274 -0.78 -77 -68 129 199
Total Gross Profit		 264 597 1,005 735 724 595 706 707 756 853 940
Total Revenue		 292 965 1,005 1,096 1,084 934 1,035 1,022 1,154 1,253 1,388
Operating Revenue		 292 965 1,005 1,096 1,084 934 1,035 1,022 1,154 1,253 1,388
Total Cost of Revenue		 27 368 0.00 361 360 339 329 315 398 400 448
Operating Cost of Revenue		 27 368 - 361 360 339 329 315 398 400 448
Total Operating Expenses		 176 564 909 983 895 869 707 784 824 724 740
Selling, General & Admin Expense		 124 355 380 465 564 514 472 469 503 509 549
Research & Development Expense		 42 82 110 146 147 153 183 156 194 183 186
Other Operating Expenses / (Income)		 - 38 - 0.00 - - 51 30 38 33 5.90
Impairment Charge		 - - 0.00 0.57 185 201 0.00 129 90 0.00 0.00
Total Other Income / (Expense), net		 0.16 -7.78 25 0.63 -17 -74 -124 1.61 -13 -41 -420
Interest Expense		 0.02 11 7.80 9.83 15 42 110 48 59 89 52
Other Income / (Expense), net		 - 1.14 40 9.60 -2.54 -32 -13 50 46 48 -368
Income Tax Expense		 31 5.11 50 -70 -30 -0.96 11 11 -99 25 22
Other Gains / (Losses), net		 - -19 -17 -0.64 0.00 -0.26 -0.15 -0.05 - - -0.05
Basic Earnings per Share		 $2.19 ($1.29) ($0.52) ($3.91) $0.00 ($7.18) ($2.68) ($1.61) $0.33 $1.17 ($4.45)
Weighted Average Basic Shares Outstanding		 26.39M 48.86M 48.16M 48.50M 48.35M 48.59M 50.63M 53.47M 53.94M 54.24M 54.55M
Diluted Earnings per Share		 $2.17 ($1.28) ($0.52) ($3.91) ($3.26) ($7.18) ($2.68) ($1.61) $0.32 $1.16 ($4.45)
Weighted Average Diluted Shares Outstanding		 26.63M 49.01M 48.50M 48.50M 48.35M 48.59M 50.63M 53.47M 54.21M 54.57M 54.55M
Weighted Average Basic & Diluted Shares Outstanding		 - 48.70M 48.20M 48.40M 48.45M 48.66M 53.26M 53.56M 53.96M 54.35M 54.69M

Quarterly Income Statements for LivaNova

This table shows LivaNova's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -7.32 16 -42 16 33 56 -327 27 27 31 22
Consolidated Net Income / (Loss)		 -7.32 16 -42 16 33 56 -327 27 27 31 22
Net Income / (Loss) Continuing Operations		 -7.32 16 -42 16 33 56 -327 27 27 31 22
Total Pre-Tax Income 		-1.98 -94 -34 22 44 56 -316 33 34 28 27
Total Operating Income		 4.46 -88 16 40 36 37 49 54 54 43 41
Total Gross Profit		 202 190 207 215 221 219 216 239 245 235 244
Total Revenue		 286 310 295 319 318 322 317 353 358 361 362
Operating Revenue		 286 310 295 319 318 322 317 353 358 361 362
Total Cost of Revenue		 84 120 88 104 97 102 101 114 113 126 119
Operating Cost of Revenue		 84 120 88 104 97 102 101 114 113 126 119
Total Operating Expenses		 197 278 191 175 185 182 168 185 191 193 202
Selling, General & Admin Expense		 135 133 130 125 127 136 129 138 139 139 144
Research & Development Expense		 47 46 46 45 49 43 38 47 49 52 59
Other Operating Expenses / (Income)		 16 8.68 16 4.84 9.18 3.40 0.61 -0.16 3.74 1.71 0.02
Total Other Income / (Expense), net		 -6.44 -6.31 -50 -19 8.86 19 -364 -21 -20 -15 -14
Interest Expense		 15 16 41 16 16 16 15 15 11 11 8.29
Other Income / (Expense), net		 8.55 9.32 -9.07 -3.05 25 35 -349 -5.93 -9.24 -4.09 -5.70
Income Tax Expense		 5.31 -111 7.72 5.23 12 0.59 12 6.15 7.11 -3.28 4.34
Other Gains / (Losses), net		 -0.03 -0.02 -0.03 -0.03 - - -0.02 -0.01 -0.01 -0.01 -0.85
Basic Earnings per Share		 ($0.14) $0.31 ($0.78) $0.30 $0.61 $1.04 ($6.01) $0.50 $0.49 $0.57 $0.41
Weighted Average Basic Shares Outstanding		 53.99M 53.94M 54.01M 54.24M 54.35M 54.24M 54.42M 54.58M 54.63M 54.55M 54.69M
Diluted Earnings per Share		 ($0.14) $0.30 ($0.78) $0.30 $0.60 $1.04 ($6.01) $0.50 $0.49 $0.57 $0.40
Weighted Average Diluted Shares Outstanding		 53.99M 54.21M 54.01M 54.59M 54.59M 54.57M 54.42M 54.71M 55.15M 54.55M 55.94M
Weighted Average Basic & Diluted Shares Outstanding		 53.87M 53.96M 54.15M 54.30M 54.30M 54.35M 54.53M 54.60M 54.61M 54.69M 54.93M

Annual Cash Flow Statements for LivaNova

This table details how cash moves in and out of LivaNova's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/24/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 21 -73 54 -46 14 192 -45 308 62 146 -88
Net Cash From Operating Activities		 80 90 91 120 -91 -79 103 70 75 183 254
Net Cash From Continuing Operating Activities		 80 90 91 120 -91 -79 103 70 75 183 253
Net Income / (Loss) Continuing Operations		 58 -63 -25 -189 -158 -349 -136 -86 18 63 -242
Consolidated Net Income / (Loss)		 58 -63 -25 -189 -158 -349 -136 -86 18 63 -242
Depreciation Expense		 5.77 40 37 70 71 67 51 48 25 25 29
Amortization Expense		 1.04 71 78 14 15 24 34 32 55 48 54
Non-Cash Adjustments To Reconcile Net Income		 12 77 115 17 223 269 103 176 140 61 407
Changes in Operating Assets and Liabilities, net		 3.07 -35 -113 210 -242 -90 50 -99 -163 -14 5.83
Net Cash From Investing Activities		 -9.77 -45 -53 -121 -41 -42 37 -38 -40 -48 -73
Net Cash From Continuing Investing Activities		 -9.77 -45 -53 -121 -41 -42 37 -38 -40 -48 -73
Purchase of Property, Plant & Equipment		 -6.69 -38 -33 -37 -25 -35 -25 -27 -35 -47 -81
Purchase of Investments		 -1.18 -8.03 -6.26 -3.77 -2.50 -3.18 -3.65 -2.95 -6.50 -1.14 -5.67
Sale of Property, Plant & Equipment		 0.00 1.15 5.94 14 - - - - 1.15 0.09 7.28
Sale and/or Maturity of Investments		 -1.90 7.00 3.19 - - - - - 0.00 0.00 6.52
Net Cash From Financing Activities		 -48 -118 11 -42 147 311 -181 280 21 19 -286
Net Cash From Continuing Financing Activities		 -48 -118 11 -42 147 311 -181 280 21 19 -286
Repayment of Debt		 0.00 -79 -11 -311 -21 -567 -486 -221 -21 -318 -281
Repurchase of Common Equity		 -55 -54 0.00 -50 -3.80 -24 - -3.29 0.00 -5.94 0.00
Issuance of Debt		 0.00 7.23 22 344 197 934 0.00 508 50 336 0.00
Other Financing Activities, net		 6.76 8.06 -0.21 -25 -26 -33 -18 -3.43 -7.48 6.68 -4.40
Effect of Exchange Rate Changes		 -0.77 -0.42 - - -0.22 2.21 -2.81 -4.01 6.19 -7.75 16

Quarterly Cash Flow Statements for LivaNova

This table details how cash moves in and out of LivaNova's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -1.64 45 38 17 33 57 15 -145 52 -11 -96
Net Cash From Operating Activities		 18 54 9.98 43 51 79 24 63 85 82 15
Net Cash From Continuing Operating Activities		 18 54 9.98 43 51 80 24 63 84 82 15
Net Income / (Loss) Continuing Operations		 -7.32 16 -42 16 33 56 -327 27 27 31 22
Consolidated Net Income / (Loss)		 -7.32 16 -42 16 33 56 -327 27 27 31 22
Depreciation Expense		 13 12 6.27 10 11 11 6.42 6.87 7.72 7.56 8.30
Amortization Expense		 6.87 8.18 12 7.13 8.04 7.82 14 14 13 13 12
Non-Cash Adjustments To Reconcile Net Income		 12 137 35 16 -2.74 2.28 371 13 13 7.76 11
Changes in Operating Assets and Liabilities, net		 -6.22 -120 -1.29 -6.62 2.16 3.42 -40 2.00 23 23 -38
Net Cash From Investing Activities		 -10 -12 -6.36 -13 -19 -11 -11 -8.97 -23 -30 -15
Net Cash From Continuing Investing Activities		 -10 -12 -6.36 -13 -19 -11 -11 -8.97 -23 -30 -15
Purchase of Property, Plant & Equipment		 -8.72 -13 -6.40 -12 -18 -10 -11 -15 -23 -32 -14
Other Investing Activities, net		 -0.18 0.72 0.04 -0.04 0.10 -0.01 0.16 -0.34 -0.18 - -0.29
Net Cash From Financing Activities		 -4.28 -5.02 37 -12 -3.28 -3.44 -4.42 -209 -9.37 -63 -94
Net Cash From Continuing Financing Activities		 -4.28 -5.02 37 -12 -3.28 -3.44 -4.42 -209 -9.37 -63 -94
Repayment of Debt		 -3.13 -4.51 -305 -3.94 -4.45 -4.38 -4.42 -205 -9.66 -62 -94
Effect of Exchange Rate Changes		 -5.44 8.35 -2.95 -1.48 4.26 -7.58 5.96 10 -0.19 0.22 -2.24

Annual Balance Sheets for LivaNova

This table presents LivaNova's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 2,559 2,343 2,504 2,550 2,412 2,400 2,201 2,295 2,430 2,506 2,606
Total Current Assets		 673 813 870 533 549 708 679 886 988 1,127 1,102
Cash & Equivalents		 113 40 94 47 61 253 208 214 267 429 636
Accounts Receivable		 272 213 282 256 258 184 185 183 215 193 216
Inventories, net		 212 133 144 154 164 115 106 129 148 148 165
Prepaid Expenses		 27 52 39 30 29 23 36 26 27 32 37
Current Deferred & Refundable Income Taxes		 42 51 46 47 38 60 38 32 20 31 49
Plant, Property, & Equipment, net		 245 204 192 191 181 164 150 147 154 170 243
Total Noncurrent Assets		 1,641 1,326 1,442 1,825 1,681 1,528 1,372 1,261 1,287 1,209 1,262
Long-Term Investments		 77 56 - - - - - - - 25 20
Goodwill		 745 692 784 957 916 922 900 769 783 750 793
Intangible Assets		 659 442 535 770 608 438 400 369 261 237 230
Noncurrent Deferred & Refundable Income Taxes		 154 6.02 12 68 69 2.99 2.20 1.38 119 112 111
Other Noncurrent Operating Assets		 5.45 131 110 30 89 165 70 123 124 85 108
Total Liabilities & Shareholders' Equity		 2,559 2,343 2,504 2,550 2,412 2,400 2,201 2,295 2,430 2,506 2,606
Total Liabilities		 747 636 689 1,046 1,028 1,291 906 1,087 1,152 1,186 1,406
Total Current Liabilities		 359 350 406 497 513 309 697 297 335 392 808
Short-Term Debt		 83 48 84 29 77 13 230 23 18 78 82
Accounts Payable		 110 72 86 77 86 74 68 74 81 70 97
Accrued Expenses		 63 71 79 124 120 88 89 81 107 118 491
Current Deferred & Payable Income Tax Liabilities		 27 18 13 23 13 16 15 17 23 32 33
Current Employee Benefit Liabilities		 77 58 66 83 70 52 79 72 95 81 93
Other Current Liabilities		 - - 0.00 162 146 36 216 29 11 13 13
Total Noncurrent Liabilities		 388 286 283 549 516 982 209 790 817 794 598
Long-Term Debt		 92 75 62 140 260 642 9.85 518 569 550 345
Noncurrent Deferred & Payable Income Tax Liabilities		 235 153 123 68 32 7.09 7.73 8.52 12 11 9.59
Noncurrent Employee Benefit Liabilities		 31 23 28 25 23 21 19 17 17 13 14
Other Noncurrent Operating Liabilities		 30 35 69 184 176 312 173 246 220 221 230
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,811 1,707 1,815 1,504 1,384 1,109 1,295 1,208 1,278 1,320 1,200
Total Preferred & Common Equity		 1,811 1,707 1,815 1,504 1,384 1,109 1,295 1,208 1,278 1,320 1,200
Total Common Equity		 1,811 1,707 1,815 1,504 1,384 1,109 1,295 1,208 1,278 1,320 1,200
Common Stock		 1,817 1,794 1,810 1,781 1,811 1,844 2,200 2,240 2,272 2,304 2,340
Retained Earnings		 48 -15 -40 -252 -407 -762 -898 -984 -966 -903 -1,146
Treasury Stock		 - -4.50 -0.13 -1.46 -1.26 -1.03 -0.65 -0.38 -0.06 -0.14 -1.17
Accumulated Other Comprehensive Income / (Loss)		 -54 -68 45 -24 -19 28 -7.18 -48 -28 -80 7.33

Quarterly Balance Sheets for LivaNova

This table presents LivaNova's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 2,213 2,295 2,342 2,329 2,460 2,453 2,522 2,559 2,507 2,558 2,516
Total Current Assets		 851 903 942 954 1,040 1,047 1,093 1,171 1,066 1,097 1,014
Cash & Equivalents		 231 214 223 234 309 329 346 738 594 646 540
Accounts Receivable		 172 178 186 190 209 201 197 202 220 212 229
Inventories, net		 122 142 156 162 153 155 162 154 165 168 166
Prepaid Expenses		 24 35 39 44 39 36 43 47 54 44 38
Current Deferred & Refundable Income Taxes		 26 24 26 26 23 22 24 29 33 28 41
Plant, Property, & Equipment, net		 139 149 150 149 152 158 169 178 195 219 255
Total Noncurrent Assets		 1,222 1,243 1,250 1,226 1,267 1,248 1,260 1,210 1,245 1,242 1,247
Long-Term Investments		 - - - - - - - - - - 18
Goodwill		 742 774 779 767 772 766 782 762 793 791 786
Intangible Assets		 365 364 357 348 254 248 249 237 239 235 225
Noncurrent Deferred & Refundable Income Taxes		 1.42 1.53 2.11 1.51 114 113 110 109 110 107 110
Other Noncurrent Operating Assets		 114 103 111 110 128 121 119 102 103 109 108
Total Liabilities & Shareholders' Equity		 2,213 2,295 2,342 2,329 2,460 2,453 2,522 2,559 2,507 2,558 2,516
Total Liabilities		 1,066 1,068 1,101 1,104 1,238 1,211 1,212 1,524 1,384 1,400 1,305
Total Current Liabilities		 288 316 288 295 328 303 324 742 827 828 762
Short-Term Debt		 22 22 19 19 20 20 22 80 130 134 62
Accounts Payable		 70 76 78 63 76 81 78 88 87 88 99
Accrued Expenses		 79 96 82 90 94 98 105 469 496 487 492
Current Deferred & Payable Income Tax Liabilities		 12 22 20 22 30 23 27 40 34 21 42
Current Employee Benefit Liabilities		 58 80 67 75 91 65 77 53 68 80 58
Other Current Liabilities		 48 19 22 27 17 16 16 13 12 16 9.64
Total Noncurrent Liabilities		 778 751 813 809 910 908 888 783 557 573 543
Long-Term Debt		 518 520 568 568 605 605 604 549 348 349 285
Noncurrent Deferred & Payable Income Tax Liabilities		 6.53 8.63 8.92 9.93 11 11 12 11 11 10 6.81
Noncurrent Employee Benefit Liabilities		 18 16 17 16 17 16 15 13 14 14 13
Other Noncurrent Operating Liabilities		 236 206 219 215 278 275 257 210 183 200 237
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,147 1,227 1,241 1,225 1,222 1,243 1,310 1,034 1,123 1,157 1,211
Total Preferred & Common Equity		 1,147 1,227 1,241 1,225 1,222 1,243 1,310 1,034 1,123 1,157 1,211
Total Common Equity		 1,147 1,227 1,241 1,225 1,222 1,243 1,310 1,034 1,123 1,157 1,211
Common Stock		 2,226 2,245 2,252 2,263 2,276 2,288 2,296 2,309 2,319 2,330 2,339
Retained Earnings		 -986 -977 -976 -983 -1,008 -992 -959 -1,231 -1,203 -1,177 -1,123
Treasury Stock		 -0.38 -0.32 -0.10 -0.06 -0.48 -0.20 -0.16 -1.43 -1.16 -1.20 -1.17
Accumulated Other Comprehensive Income / (Loss)		 -93 -41 -36 -55 -45 -53 -27 -43 8.11 5.51 -3.40

Annual Metrics And Ratios for LivaNova

This table displays calculated financial ratios and metrics derived from LivaNova's official financial filings.

Metric 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/24/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 4.16% 9.08% -1.10% -13.83% 10.82% -1.31% 12.89% 8.66% 10.74%
EBITDA Growth		 11.85% 0.00% 71.97% -161.75% 42.62% -141.57% 132.86% -25.97% 10.14% 333.82% -134.52%
EBIT Growth		 11.21% 0.00% 293.77% -275.11% 27.00% -75.64% 95.39% -90.95% 16.80% 890.52% -195.47%
NOPAT Growth		 4.46% 0.00% 111.68% -406.27% 30.85% -59.66% 99.71% -9,689.80% 10.75% 292.77% 51.00%
Net Income Growth		 0.00% 0.00% 60.04% -654.91% 16.77% -121.28% 61.06% 36.50% 120.34% 260.39% -483.45%
EPS Growth		 0.00% 0.00% 59.38% -651.92% 16.62% -120.25% 62.67% 39.93% 119.88% 262.50% -483.62%
Operating Cash Flow Growth		 0.00% 0.00% 1.32% 31.91% -175.64% 12.86% 229.11% -31.81% 7.14% 144.33% 38.95%
Free Cash Flow Firm Growth		 206.97% 0.00% 0.00% 26.79% -50.36% 98.30% 5,578.72% -73.05% -358.98% 253.21% 104.90%
Invested Capital Growth		 -5.74% 0.00% 13.23% -4.14% 2.18% -11.39% -9.86% -6.99% 4.29% -4.83% -19.05%
Revenue Q/Q Growth		 0.00% 0.00% 26.12% 1.33% 0.12% -1.74% -0.09% 0.47% 3.15% 0.94% 2.90%
EBITDA Q/Q Growth		 0.00% 0.00% 13.34% -185.45% 58.62% -169.21% 132.92% 39.74% -62.97% 147.44% -58.33%
EBIT Q/Q Growth		 0.00% 0.00% 30.74% -346.94% 42.54% -79.84% 95.34% 36.88% -129.42% 581.81% -24.99%
NOPAT Q/Q Growth		 0.00% 0.00% -44.89% -31,711.46% 43.07% -62.27% 99.72% -16.37% -1,034.95% 3,168.48% 2.87%
Net Income Q/Q Growth		 0.00% 0.00% -144.17% -109.22% 29.15% -65.42% 67.22% 7.30% 511.79% 167.01% -11.49%
EPS Q/Q Growth		 0.00% 0.00% -144.07% -109.09% 28.98% -65.06% 68.32% 5.85% 433.33% 176.19% -11.81%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -20.21% 2.74% -24.65% 30.05% -3.31% -17.45% 88.90% 15.64% 1.47%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% -2,292.93% -215.76% -15.57% 97.98% -31.43% -72.66% -7.08% 1,082.92% -10.41%
Invested Capital Q/Q Growth		 0.00% -18.21% -12.03% -11.60% -5.75% -17.07% -3.14% 4.48% 0.51% -3.57% -2.40%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 90.63% 61.88% 100.00% 67.04% 66.76% 63.66% 68.19% 69.21% 66.86% 69.48% 67.71%
EBITDA Margin		 32.74% 15.12% 24.96% -14.13% -8.20% -22.99% 6.82% 5.11% 4.99% 19.91% -6.21%
Operating Margin		 30.41% 3.47% 9.60% -22.63% -15.82% -29.32% -0.08% -7.51% -5.94% 10.30% 14.36%
EBIT Margin		 30.41% 3.58% 13.55% -21.75% -16.06% -32.73% -1.36% -2.63% -1.94% 14.11% -12.16%
Profit (Net Income) Margin		 19.84% -6.51% -2.50% -17.28% -14.54% -37.34% -13.12% -8.44% 1.52% 5.04% -17.47%
Tax Burden Percent		 64.78% -244.64% -20.71% 76.54% 83.68% 100.23% 109.12% 114.78% -21.60% 71.60% 109.82%
Interest Burden Percent		 100.72% 74.21% 88.95% 103.76% 108.21% 113.82% 883.85% 279.42% 363.05% 49.93% 130.76%
Effective Tax Rate		 35.22% 19.92% 41.24% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 28.38% 0.00%
Return on Invested Capital (ROIC)		 51.49% 1.79% 3.55% -10.46% -7.31% -12.25% -0.04% -4.20% -3.81% 7.36% 12.86%
ROIC Less NNEP Spread (ROIC-NNEP)		 51.23% 44.48% 53.11% -3,545.50% -26.19% -61.45% -68.79% -117.48% 374.07% 74.37% 231.07%
Return on Net Nonoperating Assets (RNNOA)		 -31.18% -5.47% -4.98% -0.95% -3.61% -15.74% -11.26% -2.70% 5.22% -2.49% -32.11%
Return on Equity (ROE)		 20.31% -3.68% -1.42% -11.41% -10.92% -27.98% -11.30% -6.89% 1.41% 4.87% -19.24%
Cash Return on Invested Capital (CROIC)		 57.40% 0.00% -8.85% -6.23% -9.47% -0.17% 10.33% 3.04% -8.00% 12.31% 33.91%
Operating Return on Assets (OROA)		 28.06% 1.41% 5.62% -9.44% -7.02% -12.71% -0.61% -1.20% -0.95% 7.17% -6.61%
Return on Assets (ROA)		 18.31% -2.56% -1.04% -7.50% -6.35% -14.50% -5.90% -3.84% 0.74% 2.56% -9.49%
Return on Common Equity (ROCE)		 20.31% -3.68% -1.42% -11.41% -10.92% -27.98% -11.30% -6.89% 1.41% 4.87% -19.24%
Return on Equity Simple (ROE_SIMPLE)		 20.92% -3.68% -1.38% -12.60% -11.39% -31.45% -10.49% -7.14% 1.37% 4.79% 0.00%
Net Operating Profit after Tax (NOPAT)		 57 27 57 -174 -120 -192 -0.55 -54 -48 92 140
NOPAT Margin		 19.70% 2.78% 5.64% -15.84% -11.08% -20.52% -0.05% -5.26% -4.16% 7.37% 10.06%
Net Nonoperating Expense Percent (NNEP)		 0.27% -42.69% -49.56% 3,535.04% 18.88% 49.20% 68.76% 113.28% -377.87% -67.01% -218.21%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -3.07% -2.57% 4.75% 8.58%
Cost of Revenue to Revenue		 9.37% 38.12% 0.00% 32.96% 33.24% 36.34% 31.81% 30.79% 33.14% 30.52% 32.29%
SG&A Expenses to Revenue		 42.40% 36.81% 37.82% 42.41% 51.98% 55.05% 45.58% 45.92% 44.92% 41.99% 39.54%
R&D to Revenue		 14.49% 8.51% 10.90% 13.31% 13.54% 16.37% 17.71% 15.25% 16.80% 14.56% 13.38%
Operating Expenses to Revenue		 60.23% 58.41% 90.40% 89.67% 82.58% 92.98% 68.26% 76.73% 72.80% 59.18% 53.35%
Earnings before Interest and Taxes (EBIT)		 89 35 136 -238 -174 -306 -14 -27 -22 177 -169
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 95 146 251 -155 -89 -215 71 52 58 250 -86
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 1.29 2.12 2.96 2.64 2.90 3.59 2.46 2.18 1.90 2.80
Price to Tangible Book Value (P/TBV)		 0.00 3.82 7.77 0.00 0.00 0.00 0.00 42.30 11.94 7.55 18.96
Price to Revenue (P/Rev)		 0.00 2.27 3.83 4.06 3.37 3.44 4.49 2.91 2.42 2.01 2.42
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 158.86 39.77 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.63% 2.51% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 1.48 2.30 2.82 2.37 2.46 3.53 2.43 2.17 1.98 3.22
Enterprise Value to Revenue (EV/Rev)		 0.00 2.30 3.89 4.17 3.62 3.88 4.53 2.93 2.42 1.93 2.26
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 15.22 15.57 0.00 0.00 0.00 66.40 57.40 48.60 9.69 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 64.20 28.68 0.00 0.00 0.00 0.00 0.00 0.00 13.68 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 82.89 68.88 0.00 0.00 0.00 0.00 0.00 0.00 26.17 22.43
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 24.63 42.76 37.96 0.00 0.00 45.69 42.88 37.32 13.21 12.31
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 32.42 77.00 0.00 15.65 8.51
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.07 0.08 0.11 0.24 0.59 0.19 0.45 0.46 0.48 0.36
Long-Term Debt to Equity		 0.00 0.04 0.03 0.09 0.19 0.58 0.01 0.43 0.45 0.42 0.29
Financial Leverage		 -0.61 -0.12 -0.09 0.00 0.14 0.26 0.16 0.02 0.01 -0.03 -0.14
Leverage Ratio		 1.14 1.39 1.38 1.52 1.72 1.93 1.91 1.80 1.90 1.90 2.03
Compound Leverage Factor		 1.15 1.03 1.22 1.58 1.86 2.20 16.92 5.02 6.90 0.95 2.65
Debt to Total Capital		 0.00% 6.71% 7.44% 10.07% 19.62% 37.15% 15.61% 30.96% 31.47% 32.22% 26.23%
Short-Term Debt to Total Capital		 0.00% 2.60% 4.28% 1.72% 4.50% 0.76% 14.97% 1.34% 0.97% 4.00% 5.01%
Long-Term Debt to Total Capital		 0.00% 4.11% 3.16% 8.35% 15.12% 36.39% 0.64% 29.62% 30.50% 28.22% 21.22%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 93.29% 92.56% 89.93% 80.38% 62.85% 84.39% 69.04% 68.53% 67.78% 73.77%
Debt to EBITDA		 0.00 0.84 0.58 -1.09 -3.80 -3.05 3.39 10.37 10.20 2.51 -4.95
Net Debt to EBITDA		 0.00 0.18 0.21 -0.78 -3.11 -1.88 0.45 0.50 0.15 -0.38 2.66
Long-Term Debt to EBITDA		 0.00 0.52 0.25 -0.90 -2.93 -2.99 0.14 9.92 9.88 2.20 -4.01
Debt to NOPAT		 0.00 4.59 2.57 -0.97 -2.81 -3.42 -436.45 -10.08 -12.24 6.79 3.06
Net Debt to NOPAT		 0.00 1.00 0.92 -0.70 -2.30 -2.10 -57.45 -0.48 -0.18 -1.04 -1.64
Long-Term Debt to NOPAT		 0.00 2.81 1.09 -0.80 -2.17 -3.35 -17.95 -9.64 -11.86 5.95 2.47
Altman Z-Score		 0.00 2.76 4.14 2.55 2.12 1.22 2.95 1.75 1.66 1.85 1.27
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 7.65 2.32 2.14 1.07 1.07 2.29 0.97 2.98 2.95 2.87 1.36
Quick Ratio		 6.42 0.72 0.93 0.61 0.62 1.41 0.56 1.34 1.44 1.59 1.05
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 64 0.00 -141 -103 -156 -2.64 144 39 -101 155 368
Operating Cash Flow to CapEx		 1,191.51% 242.23% 338.32% 524.60% -369.13% -226.76% 402.48% 263.68% 214.16% 388.56% 344.78%
Free Cash Flow to Firm to Interest Expense		 3,048.57 0.00 -18.12 -10.53 -10.31 -0.06 1.31 0.81 -1.71 1.74 7.09
Operating Cash Flow to Interest Expense		 3,794.10 8.49 11.71 12.26 -6.04 -1.88 0.93 1.45 1.27 2.07 4.90
Operating Cash Flow Less CapEx to Interest Expense		 3,475.67 4.99 8.25 9.93 -7.68 -2.71 0.70 0.90 0.68 1.54 3.48
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.92 0.39 0.41 0.43 0.44 0.39 0.45 0.45 0.49 0.51 0.54
Accounts Receivable Turnover		 5.77 3.97 4.06 4.07 4.22 4.23 5.60 5.55 5.79 6.14 6.79
Inventory Turnover		 1.14 2.13 0.00 2.42 2.27 2.43 2.98 2.67 2.76 2.59 2.87
Fixed Asset Turnover		 7.24 4.30 5.08 5.71 5.82 5.41 6.60 6.88 7.66 7.73 6.72
Accounts Payable Turnover		 3.77 4.05 0.00 4.44 4.43 4.26 4.65 4.42 4.93 5.08 5.37
Days Sales Outstanding (DSO)		 63.31 91.85 89.96 89.61 86.51 86.37 65.17 65.81 63.00 59.44 53.79
Days Inventory Outstanding (DIO)		 320.26 171.40 0.00 150.52 160.89 150.22 122.52 136.46 132.36 140.94 127.16
Days Payable Outstanding (DPO)		 96.91 90.06 0.00 82.15 82.36 85.78 78.50 82.56 74.07 71.83 67.95
Cash Conversion Cycle (CCC)		 286.66 173.19 89.96 157.98 165.03 150.81 109.19 119.71 121.29 128.55 112.99
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 108 1,497 1,695 1,625 1,660 1,471 1,326 1,234 1,286 1,224 971
Invested Capital Turnover		 2.61 0.64 0.63 0.66 0.66 0.60 0.74 0.80 0.92 1.00 1.28
Increase / (Decrease) in Invested Capital		 -6.59 0.00 198 -70 35 -189 -145 -93 53 -62 -228
Enterprise Value (EV)		 0.00 2,220 3,905 4,574 3,927 3,620 4,685 2,999 2,796 2,419 3,131
Market Capitalization		 0.00 2,193 3,853 4,453 3,651 3,218 4,654 2,973 2,787 2,515 3,360
Book Value per Share		 $10.48 $35.00 $37.65 $30.89 $28.59 $22.83 $24.32 $22.56 $23.72 $24.31 $21.98
Tangible Book Value per Share		 $10.09 $11.76 $10.28 ($4.59) ($2.88) ($5.16) ($0.09) $1.31 $4.33 $6.13 $3.24
Total Capital		 277 1,830 1,961 1,672 1,721 1,765 1,534 1,749 1,864 1,948 1,627
Total Debt		 0.00 123 146 168 338 656 240 542 587 628 427
Total Long-Term Debt		 0.00 75 62 140 260 642 9.85 518 569 550 345
Net Debt		 -168 27 52 121 277 403 32 26 8.78 -96 -229
Capital Expenditures (CapEx)		 6.69 37 27 23 25 35 25 27 35 47 74
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 58 471 454 18 53 160 3.89 97 93 90 -261
Debt-free Net Working Capital (DFNWC)		 209 510 548 65 114 412 212 612 671 813 375
Net Working Capital (NWC)		 209 463 464 37 37 399 -18 589 653 735 294
Net Nonoperating Expense (NNE)		 -0.42 90 82 16 38 157 135 33 -65 29 382
Net Nonoperating Obligations (NNO)		 -168 -210 -120 121 277 362 32 26 8.78 -96 -229
Total Depreciation and Amortization (D&A)		 6.81 111 115 84 85 91 85 79 80 73 83
Debt-free, Cash-free Net Working Capital to Revenue		 19.92% 48.78% 45.20% 1.65% 4.90% 17.07% 0.38% 9.45% 8.10% 7.14% -18.77%
Debt-free Net Working Capital to Revenue		 71.78% 52.90% 54.51% 5.96% 10.54% 44.14% 20.46% 59.91% 58.19% 64.87% 27.02%
Net Working Capital to Revenue		 71.78% 47.97% 46.15% 3.33% 3.40% 42.71% -1.72% 57.62% 56.62% 58.64% 21.15%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.52) ($3.91) ($3.21) ($7.10) ($2.68) ($1.61) $0.33 $1.17 ($4.45)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 48.16M 48.50M 48.35M 48.59M 50.63M 53.47M 53.94M 54.24M 54.55M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.52) ($3.91) ($3.21) ($7.10) ($2.68) ($1.61) $0.32 $1.16 ($4.45)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 48.50M 48.50M 48.35M 48.59M 50.63M 53.47M 54.21M 54.57M 54.55M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 48.30M 48.28M 48.45M 48.66M 53.26M 53.56M 53.96M 54.35M 54.69M
Normalized Net Operating Profit after Tax (NOPAT)		 63 73 76 61 9.37 -51 -0.55 37 15 92 140
Normalized NOPAT Margin		 21.63% 7.57% 7.55% 5.55% 0.86% -5.43% -0.05% 3.61% 1.30% 7.37% 10.06%
Pre Tax Income Margin		 30.63% 2.66% 12.05% -22.57% -17.38% -37.25% -12.02% -7.35% -7.04% 7.05% -15.91%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 4,221.52 3.26 17.47 -24.27 -11.54 -7.24 -0.13 -0.56 -0.38 2.00 -3.25
NOPAT to Interest Expense		 2,734.86 2.52 7.27 -17.67 -7.96 -4.54 -0.01 -1.11 -0.81 1.04 2.69
EBIT Less CapEx to Interest Expense		 3,903.10 -0.25 14.00 -26.61 -13.17 -8.07 -0.36 -1.11 -0.97 1.47 -4.67
NOPAT Less CapEx to Interest Expense		 2,416.43 -0.98 3.81 -20.01 -9.59 -5.37 -0.24 -1.66 -1.41 0.51 1.27
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 95.10% -86.78% 0.00% -26.40% -2.41% -6.80% 0.00% -3.82% 0.00% 9.39% 0.00%

Quarterly Metrics And Ratios for LivaNova

This table displays calculated financial ratios and metrics derived from LivaNova's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 54,689,876.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 54,689,876.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.41
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 13.27% 12.83% 11.96% 8.40% 11.19% 3.77% 7.44% 10.66% 12.46% 12.15% 14.33%
EBITDA Growth		 143.71% -245.61% -41.60% 38.35% 140.64% 256.46% -1,210.55% 26.14% -16.59% -34.98% 120.05%
EBIT Growth		 113.92% -498.25% -69.08% 84.78% 363.71% 191.83% -4,286.20% 29.98% -25.77% -46.72% 111.91%
NOPAT Growth		 103.38% -1,769.29% 741.22% 681.92% 745.39% 159.48% 199.26% 45.13% 61.79% 30.03% 2.62%
Net Income Growth		 93.18% 883.68% -669.10% 1,314.11% 550.30% 242.07% -680.40% 66.30% -18.72% -44.70% 106.81%
EPS Growth		 93.03% 650.00% -657.14% 1,400.00% 528.57% 246.67% -670.51% 66.67% -18.33% -45.19% 106.66%
Operating Cash Flow Growth		 -49.11% 188.50% -51.92% 341.71% 181.18% 45.87% 140.12% 45.12% 66.80% 4.69% -36.51%
Free Cash Flow Firm Growth		 -199.98% -218.82% -54.47% 71.76% 138.06% 186.22% 1,115.68% 203.74% 767.74% 122.98% -112.05%
Invested Capital Growth		 8.41% 4.29% -1.33% -4.54% -0.80% -4.83% -24.84% -18.35% -21.66% -19.05% 8.20%
Revenue Q/Q Growth		 -2.64% 8.39% -4.91% 8.02% -0.14% 1.17% -1.55% 11.26% 1.48% 0.89% 0.37%
EBITDA Q/Q Growth		 -17.04% -276.78% 143.48% 116.98% 44.30% 14.94% -408.60% 124.65% -4.58% -10.41% -4.84%
EBIT Q/Q Growth		 -35.25% -704.82% 109.12% 417.37% 62.49% 19.77% -515.74% 116.06% -7.21% -14.03% -7.05%
NOPAT Q/Q Growth		 -19.84% -2,073.76% 118.46% 167.68% -13.34% 38.87% -7.11% 29.82% -3.39% 11.61% -26.69%
Net Income Q/Q Growth		 -733.59% 323.27% -356.70% 138.94% 101.76% 69.61% -685.64% 108.30% -1.39% 15.39% -27.87%
EPS Q/Q Growth		 -800.00% 314.29% -360.00% 138.46% 100.00% 73.33% -677.88% 108.32% -2.00% 16.33% -29.82%
Operating Cash Flow Q/Q Growth		 201.11% 197.52% -81.50% 334.39% 17.62% 54.35% -69.55% 162.54% 35.18% -3.13% -81.53%
Free Cash Flow Firm Q/Q Growth		 -285.39% -19.03% 124.40% 218.94% -58.91% 169.60% 244.11% -20.31% 17.38% -13.12% -114.83%
Invested Capital Q/Q Growth		 -1.03% 0.51% -4.36% 0.35% 2.84% -3.57% -24.48% 9.02% -1.33% -2.40% 3.06%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 70.53% 61.32% 70.32% 68.70% 70.81% 68.16% 69.68% 67.79% 68.44% 65.18% 67.29%
EBITDA Margin		 11.47% -18.70% 8.55% 17.17% 24.82% 28.19% -88.37% 19.58% 18.41% 16.35% 15.50%
Operating Margin		 1.56% -28.37% 5.51% 12.61% 11.20% 11.50% 15.34% 15.37% 15.10% 11.80% 11.45%
EBIT Margin		 4.55% -25.37% 2.43% 11.65% 18.96% 22.45% -94.79% 13.69% 12.52% 10.66% 9.88%
Profit (Net Income) Margin		 -2.56% 5.27% -14.22% 5.13% 10.36% 17.37% -103.30% 7.70% 7.49% 8.56% 6.15%
Tax Burden Percent		 369.97% -17.33% 122.64% 75.65% 74.15% 98.96% 103.70% 81.52% 78.98% 111.84% 81.11%
Interest Burden Percent		 -15.21% 119.86% -476.66% 58.16% 73.68% 78.18% 105.09% 69.06% 75.74% 71.79% 76.83%
Effective Tax Rate		 0.00% 0.00% 0.00% 24.21% 25.93% 1.04% 0.00% 18.46% 20.98% -11.88% 15.79%
Return on Invested Capital (ROIC)		 0.99% -18.18% 3.69% 9.15% 8.08% 11.37% 12.71% 14.63% 14.21% 16.88% 14.36%
ROIC Less NNEP Spread (ROIC-NNEP)		 -22.70% 431.45% -372.91% -53.95% 101.10% -32.83% 729.19% 42.38% 29.88% 26.44% 22.24%
Return on Net Nonoperating Assets (RNNOA)		 -0.84% 6.02% -4.31% -0.97% 0.56% 1.10% -32.61% -2.20% -2.46% -3.67% -3.17%
Return on Equity (ROE)		 0.15% -12.17% -0.62% 8.17% 8.64% 12.47% -19.89% 12.44% 11.76% 13.21% 11.18%
Cash Return on Invested Capital (CROIC)		 -7.66% -8.00% -1.48% 3.14% 1.02% 12.31% 38.85% 31.15% 36.28% 33.91% 9.75%
Operating Return on Assets (OROA)		 2.24% -12.39% 1.21% 5.88% 9.71% 11.40% -48.18% 7.23% 6.65% 5.79% 5.58%
Return on Assets (ROA)		 -1.26% 2.57% -7.09% 2.59% 5.30% 8.82% -52.51% 4.07% 3.98% 4.65% 3.48%
Return on Common Equity (ROCE)		 0.15% -12.17% -0.62% 8.17% 8.64% 12.47% -19.89% 12.44% 11.76% 13.21% 11.18%
Return on Equity Simple (ROE_SIMPLE)		 0.23% 0.00% -2.60% -1.34% 1.81% 0.00% -21.48% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 3.12 -62 11 30 26 37 34 44 43 48 35
NOPAT Margin		 1.09% -19.86% 3.86% 9.56% 8.29% 11.38% 10.74% 12.53% 11.93% 13.20% 9.64%
Net Nonoperating Expense Percent (NNEP)		 23.69% -449.63% 376.60% 63.10% -93.02% 44.19% -716.47% -27.74% -15.67% -9.55% -7.88%
Return On Investment Capital (ROIC_SIMPLE)		 - -3.30% - - - 1.88% 2.05% 2.76% 2.60% 2.93% 2.24%
Cost of Revenue to Revenue		 29.47% 38.68% 29.68% 31.30% 29.19% 31.84% 30.32% 32.21% 31.56% 34.82% 32.71%
SG&A Expenses to Revenue		 47.11% 42.99% 44.03% 40.53% 41.39% 42.14% 42.19% 39.08% 38.72% 38.47% 39.63%
R&D to Revenue		 16.27% 14.89% 15.48% 14.04% 15.34% 13.46% 11.95% 13.38% 13.58% 14.44% 16.20%
Operating Expenses to Revenue		 68.97% 89.69% 64.81% 56.09% 59.61% 56.66% 54.33% 52.42% 53.34% 53.38% 55.84%
Earnings before Interest and Taxes (EBIT)		 13 -79 7.18 37 60 72 -300 48 45 38 36
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 33 -58 25 55 79 91 -280 69 66 59 56
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.33 2.18 2.47 2.39 2.18 1.90 2.06 2.19 2.47 2.80 2.87
Price to Tangible Book Value (P/TBV)		 25.73 11.94 15.42 13.02 10.19 7.55 59.65 27.18 21.72 18.96 17.28
Price to Revenue (P/Rev)		 2.55 2.42 2.55 2.45 2.30 2.01 1.67 1.87 2.12 2.42 2.43
Price to Earnings (P/E)		 993.49 158.86 0.00 0.00 120.46 39.77 0.00 0.00 0.00 0.00 32.44
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.10% 0.63% 0.00% 0.00% 0.83% 2.51% 0.00% 0.00% 0.00% 0.00% 3.08%
Enterprise Value to Invested Capital (EV/IC)		 2.27 2.17 2.46 2.40 2.22 1.98 2.19 2.32 2.71 3.22 3.26
Enterprise Value to Revenue (EV/Rev)		 2.60 2.42 2.55 2.45 2.27 1.93 1.59 1.79 2.00 2.26 2.28
Enterprise Value to EBITDA (EV/EBITDA)		 18.69 48.60 76.49 54.09 27.88 9.69 0.00 0.00 0.00 0.00 13.06
Enterprise Value to EBIT (EV/EBIT)		 38.18 0.00 0.00 0.00 108.42 13.68 0.00 0.00 0.00 0.00 19.52
Enterprise Value to NOPAT (EV/NOPAT)		 566.21 0.00 0.00 0.00 994.51 26.17 17.92 19.05 19.88 22.43 19.24
Enterprise Value to Operating Cash Flow (EV/OCF)		 73.22 37.32 47.20 23.60 17.77 13.21 10.28 10.80 10.76 12.31 13.30
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 74.59 215.32 15.65 4.84 6.70 6.57 8.51 34.78
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.48 0.46 0.51 0.50 0.48 0.48 0.61 0.43 0.42 0.36 0.29
Long-Term Debt to Equity		 0.46 0.45 0.50 0.49 0.46 0.42 0.53 0.31 0.30 0.29 0.24
Financial Leverage		 0.04 0.01 0.01 0.02 0.01 -0.03 -0.04 -0.05 -0.08 -0.14 -0.14
Leverage Ratio		 1.91 1.90 1.94 1.93 1.91 1.90 2.22 2.10 2.06 2.03 2.26
Compound Leverage Factor		 -0.29 2.28 -9.25 1.12 1.41 1.49 2.34 1.45 1.56 1.46 1.74
Debt to Total Capital		 32.39% 31.47% 33.83% 33.47% 32.34% 32.22% 37.81% 29.90% 29.47% 26.23% 22.29%
Short-Term Debt to Total Capital		 1.05% 0.97% 1.07% 1.06% 1.13% 4.00% 4.78% 8.14% 8.20% 5.01% 3.99%
Long-Term Debt to Total Capital		 31.34% 30.50% 32.76% 32.42% 31.21% 28.22% 33.02% 21.76% 21.27% 21.22% 18.29%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 67.61% 68.53% 66.17% 66.53% 67.66% 67.78% 62.19% 70.10% 70.53% 73.77% 77.71%
Debt to EBITDA		 3.78 10.20 15.78 11.42 6.21 2.51 -11.30 -11.59 -8.89 -4.95 1.39
Net Debt to EBITDA		 0.35 0.15 0.22 -0.15 -0.40 -0.38 1.97 2.78 2.99 2.66 -0.84
Long-Term Debt to EBITDA		 3.66 9.88 15.28 11.06 5.99 2.20 -9.87 -8.43 -6.41 -4.01 1.14
Debt to NOPAT		 114.50 -12.24 -17.87 -32.93 221.44 6.79 5.56 3.90 3.56 3.06 2.05
Net Debt to NOPAT		 10.62 -0.18 -0.25 0.42 -14.26 -1.04 -0.97 -0.93 -1.20 -1.64 -1.24
Long-Term Debt to NOPAT		 110.79 -11.86 -17.31 -31.89 213.68 5.95 4.86 2.84 2.57 2.47 1.68
Altman Z-Score		 1.80 1.59 1.73 1.81 1.82 1.71 0.48 1.09 1.29 1.53 1.71
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.23 2.95 3.17 3.45 3.37 2.87 1.58 1.29 1.33 1.36 1.33
Quick Ratio		 1.43 1.44 1.58 1.75 1.68 1.59 1.27 0.98 1.04 1.05 1.01
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -96 -114 28 89 37 99 340 271 318 276 -41
Operating Cash Flow to CapEx		 208.03% 417.66% 156.00% 356.66% 281.01% 756.36% 222.11% 415.40% 371.75% 255.63% 106.48%
Free Cash Flow to Firm to Interest Expense		 -6.42 -7.33 0.68 5.74 2.31 6.26 22.22 18.13 29.25 25.43 -4.94
Operating Cash Flow to Interest Expense		 1.21 3.45 0.24 2.79 3.21 4.99 1.57 4.21 7.83 7.59 1.84
Operating Cash Flow Less CapEx to Interest Expense		 0.63 2.63 0.09 2.01 2.07 4.33 0.86 3.20 5.72 4.62 0.11
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.49 0.49 0.50 0.50 0.51 0.51 0.51 0.53 0.53 0.54 0.56
Accounts Receivable Turnover		 6.18 5.79 6.11 6.26 6.42 6.14 6.20 6.22 6.60 6.79 6.65
Inventory Turnover		 2.49 2.76 2.57 2.52 2.47 2.59 2.55 2.51 2.53 2.87 2.92
Fixed Asset Turnover		 7.75 7.66 7.87 7.87 7.79 7.73 7.73 7.41 6.96 6.72 6.62
Accounts Payable Turnover		 5.34 4.93 5.02 4.91 5.69 5.08 4.78 4.77 5.02 5.37 4.99
Days Sales Outstanding (DSO)		 59.07 63.00 59.71 58.35 56.88 59.44 58.89 58.69 55.30 53.79 54.92
Days Inventory Outstanding (DIO)		 146.33 132.36 141.80 145.05 147.72 140.94 143.34 145.68 144.42 127.16 125.11
Days Payable Outstanding (DPO)		 68.32 74.07 72.75 74.37 64.17 71.83 76.33 76.58 72.71 67.95 73.14
Cash Conversion Cycle (CCC)		 137.08 121.29 128.76 129.03 140.42 128.55 125.89 127.79 127.00 112.99 106.89
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,280 1,286 1,230 1,235 1,270 1,224 925 1,008 995 971 1,001
Invested Capital Turnover		 0.91 0.92 0.96 0.96 0.97 1.00 1.18 1.17 1.19 1.28 1.49
Increase / (Decrease) in Invested Capital		 99 53 -17 -59 -10 -62 -306 -227 -275 -228 76
Enterprise Value (EV)		 2,904 2,796 3,027 2,961 2,812 2,419 2,025 2,340 2,697 3,131 3,265
Market Capitalization		 2,849 2,787 3,018 2,969 2,853 2,515 2,135 2,455 2,860 3,360 3,476
Book Value per Share		 $22.74 $23.72 $22.64 $22.95 $24.13 $24.31 $19.03 $20.59 $21.19 $21.98 $22.15
Tangible Book Value per Share		 $2.06 $4.33 $3.63 $4.21 $5.16 $6.13 $0.66 $1.66 $2.41 $3.24 $3.68
Total Capital		 1,813 1,864 1,846 1,868 1,936 1,948 1,663 1,602 1,641 1,627 1,559
Total Debt		 587 587 624 625 626 628 629 479 484 427 347
Total Long-Term Debt		 568 569 605 605 604 550 549 348 349 345 285
Net Debt		 54 8.78 8.77 -7.95 -40 -96 -110 -115 -163 -229 -211
Capital Expenditures (CapEx)		 8.72 13 6.40 12 18 10 11 15 23 32 14
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 145 93 116 130 124 90 -229 -224 -242 -261 -226
Debt-free Net Working Capital (DFNWC)		 677 671 732 763 791 813 509 369 404 375 314
Net Working Capital (NWC)		 658 653 712 744 769 735 430 239 270 294 252
Net Nonoperating Expense (NNE)		 10 -78 53 14 -6.57 -19 361 17 16 17 13
Net Nonoperating Obligations (NNO)		 54 8.78 8.77 -7.95 -40 -96 -110 -115 -163 -229 -211
Total Depreciation and Amortization (D&A)		 20 21 18 18 19 18 20 21 21 21 20
Debt-free, Cash-free Net Working Capital to Revenue		 12.95% 8.10% 9.81% 10.77% 9.99% 7.14% -17.98% -17.12% -17.94% -18.77% -15.75%
Debt-free Net Working Capital to Revenue		 60.58% 58.19% 61.77% 63.11% 63.67% 64.87% 39.92% 28.22% 29.95% 27.02% 21.90%
Net Working Capital to Revenue		 58.88% 56.62% 60.10% 61.48% 61.91% 58.64% 33.68% 18.26% 19.98% 21.15% 17.56%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.14) $0.31 ($0.78) $0.30 $0.61 $1.04 ($6.01) $0.50 $0.49 $0.57 $0.41
Adjusted Weighted Average Basic Shares Outstanding		 53.99M 53.94M 54.01M 54.24M 54.35M 54.24M 54.42M 54.58M 54.63M 54.55M 54.69M
Adjusted Diluted Earnings per Share		 ($0.14) $0.30 ($0.78) $0.30 $0.60 $1.04 ($6.01) $0.50 $0.49 $0.57 $0.40
Adjusted Weighted Average Diluted Shares Outstanding		 53.99M 54.21M 54.01M 54.59M 54.59M 54.57M 54.42M 54.71M 55.15M 54.55M 55.94M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 53.87M 53.96M 54.15M 54.30M 54.30M 54.35M 54.53M 54.60M 54.61M 54.69M 54.93M
Normalized Net Operating Profit after Tax (NOPAT)		 3.12 -62 11 30 26 37 34 44 43 30 35
Normalized NOPAT Margin		 1.09% -19.86% 3.86% 9.56% 8.29% 11.38% 10.74% 12.53% 11.93% 8.26% 9.64%
Pre Tax Income Margin		 -0.69% -30.41% -11.60% 6.78% 13.97% 17.55% -99.62% 9.45% 9.48% 7.66% 7.59%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.87 -5.04 0.17 2.39 3.80 4.58 -19.65 3.23 4.12 3.55 4.32
NOPAT to Interest Expense		 0.21 -3.94 0.27 1.96 1.66 2.32 2.23 2.96 3.93 4.39 4.21
EBIT Less CapEx to Interest Expense		 0.29 -5.86 0.02 1.61 2.66 3.92 -20.36 2.22 2.02 0.58 2.59
NOPAT Less CapEx to Interest Expense		 -0.37 -4.77 0.12 1.18 0.52 1.66 1.52 1.94 1.82 1.42 2.49
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 9.39% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

LivaNova (LIVN) shows a path of topline recovery in 2025 with solid profitability and healthy liquidity, though earnings volatility in a few quarters reflects ongoing earnings sensitivity to one-time items and financing activity.

  • Revenue recovery: In 2025, quarterly operating revenue sits in the mid-to-high $300s millions, with Q3 2025 around $357.8M and Q4 2025 about $360.9M, up from 2024 levels (roughly $316–$322M per quarter) and signaling top‑line improvement.
  • Robust gross margin: 2025 gross margin runs in the mid-to-high 60s% (e.g., Q4 2025 gross margin approx 65.3% and Q3 2025 about 68.4%), indicating strong profitability on product sales.
  • Healthy operating profitability: 2025 quarters show operating income in the $42–54M range, roughly 12–15% operating margin in late 2025, supported by steady gross profit generation.
  • Positive quarterly earnings after Q1 2025: Net income attributable to common shareholders is positive in Q2–Q4 2025 (Q4 around $30.9M; Q3 around $26.8M; Q2 around $27.2M), reflecting ongoing profitability aside from a one-time impairment in Q1 2025.
  • Cash flow from operations: 2025 generally shows positive cash generation, with net cash from continuing operating activities in Q3 2025 at about $83.9M and Q4 2025 at about $82.4M, though Q1 2025 was weaker due to a large one‑time item.
  • Liquidity position: Cash and equivalents remain sizable, typically in the $590M–$740M range across 2025, supporting liquidity for ongoing operations and potential strategic needs.
  • Leverage context: Long-term debt to date is manageable (long-term debt around $349M in Q3 2025; total liabilities about $1.40B; total equity near $1.16B), suggesting a moderate level of leverage for a specialty medical device/biotech company.
  • Q1 2025 impairment hit: A large impairment charge drove a substantial quarterly loss (net income to common shareholders around -$327M) in Q1 2025, weighing on quarterly profitability and creating dispersion with other quarters.
  • Financing activity headwinds: Financing cash flows were meaningfully negative in several 2025 quarters due to debt repayments, contributing to net cash outflows from financing activities (e.g., notable debt repayments in Q4 2025).
  • Earnings volatility: The combination of a late‑2024–early‑2025 impairment and quarterly variability in net income underscores earnings volatility, which can complicate near-term earnings visibility for investors.
05/18/26 01:02 PM ETAI Generated. May Contain Errors.

LivaNova Financials - Frequently Asked Questions

According to the most recent income statement we have on file, LivaNova's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

LivaNova's net income appears to be on an upward trend, with a most recent value of -$242.47 million in 2025, falling from $57.85 million in 2014. The previous period was $63.23 million in 2024. See LivaNova's forecast for analyst expectations on what's next for the company.

LivaNova's total operating income in 2025 was $199.39 million, based on the following breakdown:
  • Total Gross Profit: $939.87 million
  • Total Operating Expenses: $740.48 million

Over the last 10 years, LivaNova's total revenue changed from $291.56 million in 2014 to $1.39 billion in 2025, a change of 376.1%.

LivaNova's total liabilities were at $1.41 billion at the end of 2025, a 18.5% increase from 2024, and a 88.2% increase since 2015.

In the past 10 years, LivaNova's cash and equivalents has ranged from $39.79 million in 2016 to $635.55 million in 2025, and is currently $635.55 million as of their latest financial filing in 2025.

Over the last 10 years, LivaNova's book value per share changed from 10.48 in 2014 to 21.98 in 2025, a change of 109.7%.


Related Companies

Financial statements for NASDAQ:LIVN last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
If You Have $50k+ on Coinbase, This Will Ruin Your Day
I spent two years reverse-engineering BlackRock's exact playbook. The same framework that generates them $16.1...
Decentralized Masters | Sponsoredtc pixel
Musk’s warning just revealed a $1T opportunity
Elon Musk recently warned that AI could force governments to introduce universal income. Mode Mobile isn't wai...
Mode Mobile | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
ZENA Surges: 558% Revenue Growth Fuels Breakout Small-Cap Narrative!
ZenaTech (NASDAQ: ZENA) reported $12.9 million in full-year 2025 revenue, representing 558% year-over-year gro...
Equiscreen | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel